Phase 4 study to assess the safety of trastuzumab deruxtecan, in indian patients

Trial Identifier:	D9673L00012
Sponsor:	AstraZeneca
Start Date:	January 2025
Primary Completion Date:	October 2026
Study Completion Date:	October 2026
Condition:	Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
IN	Bangalore, IN, 560017
IN	Kochi, IN, 682041
IN	Pune, IN, 411028
IN	Varanasi, IN, 221005

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.